Pathologic report of breast cancer after preoperative chemotherapy
Chmielik, E.; Olszewski, W.P.
Polish Journal of Pathology Official Journal of the Polish Society of Pathologists 62(4 Suppl. 4): S34-S35
2011
ISSN/ISBN: 1233-9687 PMID: 22693731 Document Number: 648078
Document emailed within 1 workday
Related Documents
Rai, Y.; Sagara, Y.; Sagara, Y.; Takahama, T.; Matsuyama, Y.; Ando, M.; Sagara, Y.; Ooi, Y.; Inoue, K.; Kurosumi, M. 2007: Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(1): 65-68Gol'dman, V.G. 1975: Immediate results of the preoperative chemotherapy of breast cancer Voprosy Onkologii 21(10): 19-22
Denkert, C.; Schickling, O.; von Minckwitz, G. 2006: Preoperative chemotherapy in breast cancer and the development of new predictive markers Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 114-123
Kurumiya, Y.; Sakamoto, E. 2019: A Case of Breast Cancer That Was Able to Accomplish Six Courses of TAC for Preoperative Chemotherapy Using Pegfilgrastim Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(7): 1179-1181
Ohta, K.; Dohden, K.; Morishita, M.; Hayashi, H.; Hattori, M.; Hosokawa, O.; Morita, M.; Kaizaki, Y.; Kiya, T. 2006: Clinical examination of safety and effectiveness of primary chemotherapy with CEF followed by docetaxel in preoperative breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 199-202
Tran, T.M.; Guittard, T.; Duchatelle, V.; Amouroux, J.; Guillevin, L.; Tricoire, J. 1989: Preoperative chemotherapy in breast cancer. Results based on the size of the tumor and multiple foci (95 patients) Annales de Medecine Interne 140(7): 647-648
Niu, Z.-H.; Wang, Y.; Chun, B.; Li, C.-X.; Wu, L. 2013: Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer European Review for Medical and Pharmacological Sciences 17(10): 1337-1344
Blohmer, J.U.; Paepke, S.; Kissner, L.; Elling, D.; Fleige, B.; Grineisen, Y.; Lichtenegger, W. 1999: Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission Zentralblatt für Gynakologie 121(11): 522-525
Kashiwagi, S.; Ishihara, S.; Ishii, M.; Asano, Y.; Watanabe, M.; Morisaki, T.; Aomatsu, N.; Noda, S.; Kawajiri, H.; Nakano, T.; Kawakami, N.; Mitsukawa, Y.; Takashima, T.; Onoda, N.; Ishikawa, T.; Hirakawa, K. 2013: Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2384-2386
Al-Saleh, K.; Abd El-Aziz, N.; Ali, A.; Abo Zeed, W.; Salah, T.; Elsamany, S.; Rasmy, A.; El Farargy, O.; Husain, S.; Al-Rikabi, A.; Alsaeed, E.; Aldiab, A.; Abd El-Warith, A. 2019: A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC) Gulf Journal of Oncology 1(30): 33-42
Takiguchi, N.; Souda, H.; Tonooka, T.; Ikeda, A.; Nabeya, Y.; Kainuma, O.; Saito, H.; Arimitsu, H.; Kobayashi, R.; Chibana, T.; Sasaki, K.; Ishige, F.; Nagata, M.; Yamamoto, H.; Denda, T. 2015: The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1475-1478
Kato, T.; Kojima, H.; Hirai, T.; Sakamoto, J.; Yasui, K.; Yamamura, Y.; Yasue, M.; Kito, T.; Miyaishi, S.; Nakazato, H. 1989: The correlation between preoperative pathologic diagnosis of a biopsy specimen and postoperative pathologic diagnosis of a tissue specimen involving colorectal cancer patients Gan no Rinsho. Japan Journal of Cancer Clinics 35(10): 1119-1122
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Hahn, K.A.; Bravo, L.; Avenell, J.S. 1994: Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer In Vivo 8(5): 825-828
Vagliasindi, A.; Valmori, L.; Bertagni, A.; Campisi, A.; Milandri, C.; Gianpalma, E.; Calzolai, F.; Golfieri, D.R.; Verdecchia, G.M. 2003: Locoregional chemotherapy of locally advanced breast cancer in a pre-treated patient: case report Tumori 89(4 Suppl): 152-154
Imamura, H.; Takatsuka, Y.; Shin, E.; Okamura, Y.; Tono, T.; Tamaki, Y.; Yagyu, T.; Kobayashi, K.; Kikkawa, N. 1994: Intra-arterial infusion chemotherapy for recurrent breast cancer via an implantable system--the second report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(13): 2270-2273
Tanaka, R.; Fukushima, H.; Sato, K.; Matsuda, M.; Hanaoka, T.; Goya, T. 1999: Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(11): 1647-1650
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Hubay, C.A.; Pearson, O.H.; Marshall, J.S.; Rhodes, R.S.; Debanne, S.M.; Mansour, E.G.; Hermann, R.E.; Jones, J.C.; Flynn, W.J.; Eckert, C.; McGuire, W.L. 1980: Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report Surgery 87(5): 494-501